Skip to main content
. Author manuscript; available in PMC: 2011 Mar 18.
Published in final edited form as: Adv Drug Deliv Rev. 2009 Nov 24;62(4-5):518–531. doi: 10.1016/j.addr.2009.11.021

Figure 10.

Figure 10

Schematic representation of a monodisperse biodegradable dimeric nanocarrier composed of peptidic backbone irreversibly or reversibly conjugated with one or more targeting ligand/drug either directly or through the distal ends of PEG [66].